Search results for " THROMBOSIS"

showing 10 items of 328 documents

COVID-19 Vaccine-Related Thrombosis: A Systematic Review and Exploratory Analysis

2021

IntroductionThe World Health Organization declared the coronavirus disease 2019 (COVID-19) pandemic on March 11, 2020. Two vaccine types were developed using two different technologies: viral vectors and mRNA. Thrombosis is one of the most severe and atypical adverse effects of vaccines. This study aimed to analyze published cases of thrombosis after COVID-19 vaccinations to identify patients’ features, potential pathophysiological mechanisms, timing of appearance of the adverse events, and other critical issues.Materials and MethodsWe performed a systematic electronic search of scientific articles regarding COVID-19 vaccine-related thrombosis and its complications on the PubMed (MEDLINE) d…

Settore BIO/17 - Istologiamedicine.medical_specialtyImmunologyMEDLINEvaccine-related thrombosisSettore MED/43 - Medicina LegalePF4 antibodiesInternal medicinePandemicmedicineCOVID 19 Vaccine Vaccine ThrombosisImmunology and AllergyPlateletAdverse effectvaccine complicationsbiologybusiness.industryvaccine adverse effectsRC581-607medicine.diseaseThrombosisPathophysiologyVaccinationbiology.proteinSystematic ReviewImmunologic diseases. AllergyAntibodybusinessCOVID-19 vaccineFrontiers in Immunology
researchProduct

SUPERIOR MESENTERIC VEIN THROMBOSIS AND CYTOMEGAOLOVIRUS: A DIAGNOSTIC DILEMMA, A CASE REPORT AND REVIEW OF THE LITERATURE

2014

Superior mesenteric vein thrombosis (SMVT) is a rare condition, usually caused by infections, intra-abdominal inflammatory diseases, portal hypertension, hypercoagulable states, or contraceptive therapy. Due to its vague symptomatology, SMVT is often diagnosed only after an abdominal contrast-enhanced computed computed tomography (CT) scan. In this article, we present a case of SMVT in a patient with a history of contraceptive drug use and a recent cytomegalovirus infection. A 36-year-old female was admitted to our department with the clinical symptoms of an acute appendicitis. the patient was a smoker and had been using hormonal contraceptive for over a year. surgery was deemed the best co…

Settore MED/18 - Chirurgia GeneraleSUPERIOR MESENTERIC VEIN THROMBOSIS CYTOMEGALOVIRUS INFECTION
researchProduct

Vascular complications on arterial puncture site after coronaric and peripheral angiography

2011

Il cateterismo cardiaco, l'angiografia coronarica e periferica e le procedure interventistiche sono tecniche contrastografiche che prevedono la visualizzazione radiografica dei vasi coronarici e periferici dopo l'iniezione selettiva di mezzo di contrasto radiopaco. Si tratta di tecniche relativamente sicure, anche se esiste un certo rischio di morbilità e mortalità. Nel nostro studio abbiamo valutato le varie complicanze mettendole in relazione con fattori demografici e clinici, terapie, caratteristiche della puntura e della procedura.

Settore MED/22 - Chirurgia Vascolarevascular complications arteriovenous fistula hematoma retroperitoneal hemorrhage pseudoaneurysm thrombosis coronaric and peripheral angiography
researchProduct

The magnesium global network (MaGNet) to promote research on magnesium in diseases focusing on covid-19

2021

When the current SARS-CoV-2 pandemic began in early 2020, the global magnesium researcher community came together and noted the striking similarities between COVID-19 risk factors and conditions associated with magnesium deficit state in humans, reasoning that magnesium deficiency could worsen the course of COVID-19 [1-4]. This prompted establishment of a worldwide collaborative network with regular virtual meetings to brainstorm the associations between magnesium and COVID-19. We hypothesize that magnesium deficiency, a common but mostly unrecognized state in modern global societies, could be an important component of the susceptibility to SARS-CoV-2 infection. Consequently, restoring the …

Societies ScientificAgingSupplementationComorbidityMetabolic DiseasesSettore MED/04 - PATOLOGIA GENERALENeoplasmsHypomagnesaemiaCardiovascular DiseaseHumansMagnesiumObesityDisease severityNutritionInflammationPreventionResearchCOVID-19ThrombosisScientificHypermagnesaemiaCongresses as TopicMetabolic DiseaseCardiovascular DiseasesImmune SystemICUThrombosiNeoplasmDisease Susceptibilityhypomagnesaemia hypermagnesaemia inflammation thrombosis prevention disease severity supplementation nutrition ICUSocietiesMagnesium DeficiencyDisease severity; Hypermagnesaemia; Hypomagnesaemia; ICU; Inflammation; Nutrition; Prevention; Supplementation; Thrombosis; Aging; COVID-19; Cardiovascular Diseases; Comorbidity; Congresses as Topic; Disease Susceptibility; Humans; Immune System; Inflammation; Magnesium; Magnesium Deficiency; Metabolic Diseases; Neoplasms; Obesity; Research; Societies ScientificHuman
researchProduct

Position paper on laboratory testing for patients on direct oral anticoagulants. A Consensus Document from the SISET, FCSA, SIBioC and SIPMeL

2018

Although direct oral anticoagulants (DOAC) do not require dose-adjustment on the basis of laboratory test results, the measurement of their anticoagulant effect is useful in special situations. This position paper issued by the Italian Scientific Societies that are mainly involved in the management of patients on DOAC is aimed at providing guidance to care-givers on which tests should be used and the situations in which testing is useful. The guidance is based on the data from the literature so far available and/or on consensus among experts.

Societies ScientificOralConsensusDOACAnticoagulantAnticoagulation; Consensus; DOAC; Thrombosis; Administration Oral; Anticoagulants; Drug Monitoring; Humans; Italy; Societies Scientific; Immunology and Allergy; HematologyAdministration OralAnticoagulantsConsensuThrombosisScientificHematologyLong-Term CareAnticoagulationSettore BIO/12 - Biochimica Clinica E Biologia Molecolare ClinicaItalyThrombosiAdministrationHumansImmunology and AllergyPosition PaperDOAC; anticoagulation; thrombosis; consensusDrug MonitoringSocietiesHuman
researchProduct

Transarterial chemoembolization and sorafenib in patients with intermediate-stage hepatocellular carcinoma: time to enter routine clinical practice?

2015

According to the guidelines of the European Association for the Study of the Liver (EASL), patients affected from hepatocellular carcinoma (HCC) can be classified according to the Barcelona Clinic Liver Cancer (BCLC) staging system. This classification system divides HCC patients in five stages (0, A, B, C and D) on the basis of a number of prognostic and treatment- related variables such as tumor status and liver function. A specific treat ment approach is then proposed for each of the above-mentioned stages. Transarterial chemoembolization (TACE) is recommended as first-line therapy in the treatment of patients with intermediate-stage (BCLC-B class) HCC [1]. The efficacy of this procedure…

SorafenibOncologyNiacinamideCancer Researchmedicine.medical_specialtyCarcinoma HepatocellularCombination therapyHCC; TACE; combination therapy; intermediate stage; sorafenibAntineoplastic Agentscombination therapyInternal medicineMedicineHumansStage (cooking)Chemoembolization TherapeuticHCCProtein Kinase InhibitorsTACEintermediate stagePerformance statusbusiness.industryPhenylurea CompoundsLiver NeoplasmsGeneral Medicinemedicine.diseaseCombined Modality Therapydigestive system diseasesPortal vein thrombosisSurgeryOncologyHepatocellular carcinomasorafenibLiver functionbusinessLiver cancermedicine.drug
researchProduct

Venous Thrombosis Associated with HMG-CoA Reductase Inhibitors

2013

Abstract Among the various hypolipidemic drugs, 3-hydroxy-3-methyl-glutaryl-coenzyme A (HMG-CoA) reductase inhibitors (also known as "statins") belong to a heterogeneous class of compounds, sharing an identical hypocholesterolemic effect that develops through direct inhibition of a rate-limiting step in endogenous cholesterol synthesis. Their mechanism of action entails competitive inhibition of HMG-CoA reductase. Several lines of evidence suggest that the pleiotropic effects of statins may also play a role in prevention of venous thrombosis, wherein hypercholesterolemic patients are characterized by enhanced thrombin generation, increased susceptibility to endothelial dysfunction and plate…

Statinmedicine.drug_classHMG-CoA; statins; thrombosisPharmacologyReductaseRisk AssessmentstatinsHyperlipoproteinemia Type IIHMG-CoARisk FactorsmedicineHumansPlateletEndothelial dysfunctionthrombosisHypolipidemic AgentsVenous Thrombosisbiologybusiness.industryC-reactive proteinHematologymedicine.diseaseThrombosisVenous thrombosisHMG-CoA reductasebiology.proteinHydroxymethylglutaryl-CoA Reductase InhibitorsCardiology and Cardiovascular MedicinebusinessSeminars in Thrombosis and Hemostasis
researchProduct

Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality

2022

[Background and Purpose] Recent studies suggested an increased incidence of cerebral venous thrombosis (CVT) during the coronavirus disease 2019 (COVID-19) pandemic. We evaluated the volume of CVT hospitalization and in-hospital mortality during the 1st year of the COVID-19 pandemic compared to the preceding year.

StrokeVaccine-induced immune thrombotic thrombocytopeniaSDG 3 - Good Health and Well-beingCerebral venous thrombosisSARS-CoV-23112 NeurosciencesCOVID-19COVID-19; Cerebral venous thrombosis; Vaccine-induced immune thrombotic thrombocytopenia; Mortality; SARS-CoV-2; StrokeNeurology (clinical)MortalityCardiology and Cardiovascular Medicine3124 Neurology and psychiatryCOVID-19; Cerebral venous thrombosis; Mortality; SARS-CoV-2; Stroke; Vaccine-induced immune thrombotic thrombocytopeniaJournal of Stroke
researchProduct

Results of isolated posterolateral corner reconstruction

2010

Abstract Background Isolated posterolateral corner (PLC) tears are relatively rare events. Various surgical techniques to treat posterolateral knee instability have been described; because surgical results are linked to cruciate reconstructions it has been difficult to date to define whether one surgical procedure has better prognosis than another. The goal of this study is to determine the clinical outcome of PLC reconstruction following fibular-based technique. Materials and methods We retrospectively evaluated a case series of patients who received isolated PLC reconstruction between March 2005 and January 2007. Ten patients were surgically treated for isolated injuries and were availabl…

Surgical resultsMaleKnee JointPosterolateral corner (PLC) reconstructionKnee JointTendonsPostoperative ComplicationsSettore MED/33 - Malattie Apparato LocomotoreOrthopedics and Sports MedicineOrthopedic ProceduresRange of Motion ArticularVenous ThrombosisFibular collateral ligamentPosterolateral corner (PLC) reconstruction Fibular collateral ligament Knee ligament reconstruction Popliteofibular ligamentMiddle Agedmusculoskeletal systemTreatment OutcomePopliteofibular ligamentLigaments ArticularOriginal ArticleFemaleRadiologyRange of motionOrthopedic Proceduresmusculoskeletal diseasesAdultJoint InstabilityReoperationmedicine.medical_specialtyAdolescentKnee InjuriesTransplantation AutologousYoung AdultmedicinePosterolateral cornerHumansFibular collateral ligamentRetrospective StudiesArthritis Infectiousbusiness.industryKnee ligament reconstructionPlastic Surgery ProceduresSurgeryTransplantationOrthopedic surgeryChronic DiseaseSurgerybusinessPulmonary EmbolismFollow-Up Studies
researchProduct

Inflammation in Ischemic Stroke Subtypes

2011

Determining the cause of stroke does influence choices for management. categorization of subtypes of ischemic stroke has had considerable study, but definitions are hard to formulate and their application for diagnosis in an individual patient is often problematic. Cerebral ischemia initiates a complex cascade of events at genomic, molecular, and cellular levels, and inflammation is important in this cascade. In 1993 for For the Trial of Org 10172 in Acute Stroke Treatment (TOAST), Adams et al] conducted a placebo-controlled, randomized, blinded study of the low-molecular-weight heparinoid given to patients within 24 hours after stroke and developed a system for diagnosis of subtype of isch…

TOAST Classificationmedicine.medical_specialtySettore MED/09 - Medicina InternaIschemiaInflammationstroke subtype stroke TOASTBrain damageSeverity of Illness IndexBrain IschemiaInternal medicineOutcome Assessment Health CareDrug DiscoverySeverity of illnessmedicineAnimalsHumanscardiovascular diseasesStrokeInflammationPharmacologyInterleukin-6business.industrymedicine.diseaseSurgeryStrokeVenous thrombosisC-Reactive ProteinSubtypes ischemic stroke TOASTEtiologyCardiologyCytokinesmedicine.symptombusinessCurrent Pharmaceutical Design
researchProduct